|
|
Subject:
taxes due on 2004 sale of stock which has merged twice and also posted dividend
Category: Business and Money > Accounting Asked by: jeanart2-ga List Price: $50.00 |
Posted:
07 Feb 2005 07:17 PST
Expires: 09 Mar 2005 07:17 PST Question ID: 470327 |
What is my capital gains tax due in year 2004 from sale of following stock (from first brokerage account and from second brokerage account) based on the transactions listed below? Purchased 25 shares of Agouron on 07/08/1996 @ 43.000 for total price of $1094.95. This transaction was made in my first brokerage account. Account Statement of 08/1997 in first brokerage account reads as follows: Activity Date: 08/28/97 Transaction: Dividend Quantity: 25 Description: Dividend and Interest: Agouron Pharm. Account Positions on Statement of 08/1997 then showed holdings of 50 Agouron (AGPH) @ 44.000 for a value of $2,200.00. Merger of 50 Agouron on 05/19/99 to Warner Lambert. Account Positions on Statement of 05/1999 then showed holding of 44 Warner Lambert (WLA) @ 62.00 for a value of $2,728.00. Merger of 44 Warner Lambert on 06/22/00 to 121 Pfizer shares. Account Positions on Statement of 06/2000 then showed holding of 121 Pfizer (PFE) @ 48.00 for a value of $5,808.00 in my first brokerage account. Transfer 50 Pfizer shares to my second brokerage account on 04/11/02 @ 36.7600 with a value of $1,838.00 from my first brokerage account. Sold 71 Pfizer from first brokerage account on 01/28/04 @ 36.16000 for a sale price of $2,567.36 with commission of $19.99 and fees of $3.13 for a net price of $2,544.24. Sold 50 Pfizer from second brokerage account on 09/20/04 for a sale price of #1,570.00 with commission of $24.95 and a fee of .04 for a net price of $1,545.01. I need the actual figures of my capital gains from both sales in 2004 for my tax obligations in 2004, not just a theoretical explanation of the process. Thanks |
|
Subject:
Re: taxes due on 2004 sale of stock which has merged twice and also posted dividend
Answered By: wonko-ga on 07 Feb 2005 09:46 PST Rated: |
The solution to your problem is to calculate the cost basis of your Pfizer shares, multiply that by the number of shares sold, and then subtract that from your sales proceeds. You began with 25 shares and wound up with 121 shares. Because none of these share exchanges were taxable events (see sources), your total cost basis was unaffected by these transactions. As a result, we can simply divide your total cost basis by 121 to determine your cost basis in Pfizer shares. Your total purchase price of $1094.95/121 = $9.04917. For your first sale of 71 shares, your cost basis is 71 multiplied by $9.04917 or $642.49. Subtracting this from your proceeds of $2544.24 results in a long-term capital gain of $1901.75. For your second sale of 50 shares, your cost basis is 50 multiplied by $9.04917 or $452.46. Subtracting this from your proceeds of $1545.01 results in a long-term capital gain of $1092.55. Therefore, your total long-term capital gain is $2994.30. Sincerely, Wonko Sources: "On July 30, 1997 the company's Board of Directors approved a two-for-one stock split in the form of a special stock dividend of one share of common stock for each share of the company's common stock outstanding. The record date for the transaction is August 15, 1997 and the closing date will be on or about August 29, 1997." "Agouron Pharmaceuticals Reports Fourth Quarter and Fiscal 1997 Financial Results; Announces 2 For 1 Stock Split" PRNewswire (July 15, 1997) http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=105&STORY=/www/story/7-31-97/289088 "The transaction will be accounted for as a pooling of interests and is intended to qualify as a tax-free exchange." "Warner-Lambert to Acquire Agouron for $2.1 Billion in Stock; Two Industry Leaders to Build Complementary Capabilities in Drug Discovery" PRNewswire (January 26, 1999) http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=105&STORY=/www/story/01-26-1999/0000854854 "The merger qualified as a tax-free reorganization and was accounted for as a pooling of interests under APB No. 16, Business Combinations." "Annual Report 2001" Pfizer http://www.pfizer.com/are/investors_reports/annual_2001/p2001ar45.html |
jeanart2-ga
rated this answer:
and gave an additional tip of:
$10.00
I am very pleased with the answer to my question. I was particularly impressed that Sources were noted. The Researcher also sent exact figures that I had requested, not just instructions on how to come up with them. I am also pleased with the quick response to my question. With sincere thanks. |
|
There are no comments at this time. |
If you feel that you have found inappropriate content, please let us know by emailing us at answers-support@google.com with the question ID listed above. Thank you. |
Search Google Answers for |
Google Home - Answers FAQ - Terms of Service - Privacy Policy |